Cocrystal Pharma, Inc. (COCP)

Cocrystal Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	4.76	7.1	9.94	26.43	37.22	58.76
Cash & Short-Term Investments	4.76	7.1	9.94	26.43	37.22	58.76
Cash Growth	-31.96%	-28.54%	-62.41%	-28.99%	-36.65%	77.72%
Other Receivables	0.76	0.71	1.22	0.89	0.72	-
Total Trade Receivables	0.76	0.71	1.22	0.89	0.72	-
Other Current Assets	0.42	0.33	0.43	1.77	2.24	0.57
Total Current Assets	5.94	8.13	11.58	29.09	40.18	59.32
Net Property, Plant & Equipment	1.39	1.48	1.85	2.12	0.62	0.93
Goodwill	-	-	-	-	-	19.09
Other Long-Term Assets	0.1	0.1	0.03	0.05	0.05	0.05
Total Assets	7.43	9.71	13.46	31.26	40.84	79.39

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1.89	1.88	2.13	3.02	0.98	1.3
Current Portion of Leases	0.34	0.33	0.3	0.24	0.24	0.24
Other Current Liabilities	-	-	-	-	-	0.01
Total Current Liabilities	2.23	2.21	2.43	3.26	1.22	1.55
Long-Term Leases	1.08	1.17	1.51	1.61	0.06	0.3
Total Long-Term Liabilities	1.08	1.17	1.51	1.61	0.06	0.3
Total Liabilities	3.31	3.38	3.93	4.88	1.27	1.84

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-in Capital	348.65	348.57	342.93	342.29	337.49	336.63
Retained Earnings	-344.55	-342.25	-333.42	-315.91	-297.93	-259.09
Shareholders' Equity	4.12	6.33	9.52	26.38	39.57	77.55
Total Liabilities & Equity	7.43	9.71	13.46	31.26	40.84	79.39

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	1.42	1.51	1.81	1.85	0.3	0.53
Net Cash (Debt)	3.34	5.6	8.13	24.58	36.92	58.22
Net Cash Growth	-36.61%	-31.17%	-66.92%	-33.44%	-36.58%	79.34%
Net Cash Per Share	0.27	0.50	0.80	2.55	4.53	7.91
Book Value	4.12	6.33	9.52	26.38	39.57	77.55
Book Value Per Share	0.34	0.56	0.94	2.73	4.86	10.53
Tangible Book Value	4.12	6.33	9.52	26.38	39.57	58.46
Tangible Book Value Per Share	0.34	0.56	0.94	2.73	4.86	7.94

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: May 15, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 11, 2026

Data Sources Report a data error